We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lionsgold | LSE:LION | London | Ordinary Share | GG00B3M9KL68 | ORD NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.65 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
24/10/2017 23:02 | 1rodson26 Sep '17 - 11:03 - 434 of 458 0 1 turned into a right little dead duck did this as boring as watching paint dry. Cameron is speaking tomorrow night you can guarantee the share price will fall on Thursday. | kimboy2 | |
24/10/2017 20:51 | as I said guys keep watching this space not only will the Lion roar but it will soon be flying. For those no believers please ignore this post. | 1rodson | |
22/10/2017 13:49 | further proof S7 is totally twisted thru expended his family's financial reserves on his lost cause called GOLDPLAT. He claims Dan said buy AFPO. Go the BBs there you will see that Dan clearly stated for those still in and have not followed him out now please to get out now that they brought in Peter Hain as AFPO will now be doomed to fail. Problem with gamblers like S7 and KB2 they go in too heavy OFTEN BORROWING MONEY TO DO SO and when they cant get out without losing a fortune they aim for the jugular of anyone that dares to criticise GOLDPLAT HOWEVER, YOUR INVESTMENT IS SOUND IN THE LION WHICH IS ABOUT TO ROAR ALL THE WAY TO STOCKMARKET SUCCESS. | 1rodson | |
19/10/2017 10:49 | The co-operation with Nigel Verdon and Clive Mitchell is interesting, they have form, Trac's vision getting some serious attention. | paleje | |
19/10/2017 09:12 | Why would anybody lodge their life savings in a gold account at a dodgy outfit like Lion, who are barely surviving. If it is such a good idea I am sure much bigger players will soon ruin the game for Lion. Meanwhile the Indian venture feasibility study has shown it to be a non starter and as for Finland... About time for another fundraising isn't it. | kimboy2 | |
18/10/2017 22:22 | man this is going to be massive. For the non-believers here just ignore me and don't buy it. RNS Number : 9813T Lionsgold Limited 18 October 2017 18 October 2017 Lionsgold Limited ("Lionsgold", "LION" or the "Company") Fintech Gold Update - Goldbloc Lionsgold, the gold-focused exploration company with assets in India and Finland, and a fintech subsidiary that provides online accounts backed by physical gold, is pleased to report on its work in developing its offering under its majority owned subsidiary TRAC Technology Ltd ("TRAC") with a view to providing a global digital currency backed by gold ("Goldbloc") (www.goldbloc.com). Highlights · Goldbloc aims to provide the convenience and utility of a fiat currency bank account, but representing direct ownership of physical gold by the Goldbloc holder. · Each Goldbloc unit will represent 1/1,000 of a gram of physical gold (approximately £0.03 based on the current gold spot price) and shall be divisible to two decimal places. · Goldbloc is the evolution of TRAC's offering of an online physical gold holding and trading account to become a gold-backed digital currency and banking platform. · To achieve this TRAC has partnered with Railsbank Limited (www.railsbank.com) to integrate its exchange platform and accounts ledger with Railsbank's banking and compliance platform that is designed to connect a global network of partner banks through its proprietary application programming interface ("API"). · Market research on Goldbloc is being conducted during November around the upcoming product(s), services and pricing models, with the initial Goldbloc product scheduled for release by the end of this year. Cameron Parry, Lionsgold CEO, commented: "We are delighted to be able to announce Goldbloc which we have been developing within Lionsgold's fintech subsidiary. Goldbloc is designed to be used as a gold-backed digital currency and banking platform, to enable individuals to hold their wealth securely in gold and spend their gold with the convenience of everyday banking. "We are also pleased to report that TRAC's CEO Ralph Hazell is working with Nigel Verdon (founder of Currency Cloud) and his Railsbank co-founder Clive Mitchell and their team to utilise the Railsbank global banking and compliance platform. "We look forward to providing further updates in regards to Goldbloc over the coming weeks." About TRAC (trading as The Real Asset Company) The Real Asset Company enables individuals to buy gold and silver bullion securely and efficiently. The user-friendly platform sits on top of world class global vaulting infrastructure, providing an online account for buying gold and silver and holding precious metals. Goldbloc is the culmination of ongoing work by TRAC and LION in evolving the original TRAC product offering available via www.therealasset.co. In July 2017, Lionsgold announced it was increasing to a majority shareholding in TRAC Technology Limited of 55% and in concert with Lionsgold CEO Cameron Parry, holds a total of 60% of the subsidiary. About Railsbank Railsbank is a banking and compliance platform that connects together a global network of partner banks with companies who want API access to global banking. Railsbank simplifies on-boarding companies to our banking partners, then gives access via the Railsbank API to banking services such as creating digital ledgers, connecting digital ledgers to real bank accounts, issuing IBANs for ledgers, receiving money, sending money, converting money (FX), collecting money (direct debit), issuing cards, and managing credit. | 1rodson | |
18/10/2017 16:05 | well, chaps time to start filling your Christmas stockings with these little guys. The potential here is rather stunning for those who can see around the corner. | 1rodson | |
10/10/2017 21:45 | exactly KB2 I could not have said it better. Investing now is for the future and LION has an excellent future soon the revenue will flow. I don't have to ramp it the facts are all in the RNS notices. All I see with GOLDPLAT'S RNS NOTICES IS PROBLEM AFTER PROBLEM. South America will break Goldplat if the Rand case does not In the end, the numbers will tell the story. | 1rodson | |
10/10/2017 15:42 | Well Lion has no cash, plenty of calls on cash in the future and no income. Goldplat has operating cash flow of £4m which isn't bad for a £10m company. It also has three profitable arms and is on a prospective p/e of under 4. You keep ramping and I will just point to the facts. it doesn't bother me whther people go and buy GDP atm. In the end the numbers will tell the story. | kimboy2 | |
09/10/2017 22:09 | beginning to pay off hxxps://youtu.be/_iM | 1rodson | |
08/10/2017 16:37 | Dan How much did you lose on this calamity last month. | kimboy2 | |
08/10/2017 16:24 | Lion is "Well Worth" a punt this coming weak....you heard it here first. hxxps://www.voxmarke | 1rodson | |
08/10/2017 13:59 | Merrill Lynch Ups Motif Bio Stake Following Iclaprim Results (ALLISS) By Alliance | Fri, 6th October 2017 - 14:19 LONDON (Alliance News) - Merrill Lynch International has raised its stake Motif Bio PLC under a transaction on Wednesday and now holds 5.038% interest in the pharmaceutical company. The purchase came on the same day Motif Bio reported positive results from its phase III clinical study of flagship antibiotic Iclaprim. Iclaprim met its primary endpoint in the phase III trial in patients with acute bacterial skin and skin structure infections, which was non-inferiority whilst compared to the standard of care vancomycin. Earlier today, Motif Bio released new pre-clinical data showing positive results regarding the use of Iclaprim. In an in vivo model mimicking the pathophysiology observed in cystic fibrosis patients, rats were dosed with either 80 or 60 milligrams of Iclaprim, 50 mg of Vancomycin, and a placebo. The Iclaprim rats showed a 100% survival rate, 33 out of 33, while Vancomycin showed 92% survival rate and the placebo 48%. Merrill Lynch had a holding that was below the notable threshold prior to the purchase. Motif Bio shares were up 6% on Friday at 46.11 pence. By Joshua Warner; joshuawarner@allianc Read more: A step ahead of ImmuPharma is Motif Bio, which has successfully completed not one, but two phase III clinical trials and is preparing to submit its antibiotic, iclaprim, for regulatory sign-off. While the shares are up 23 per cent this week at around 43p, analysts think it could be worth double that figure. Amphion Innovations, the investment group, owns just over 14 per cent of Motif. Its chief executive thinks market hasn’t quite grasped how valuable this shareholding is. He might be right as Amphion’s market capitalisation is some way short of the value of its Motif investment | cool druid | |
08/10/2017 13:58 | Did some fart, or did a little fart utter a noise. Go course you have to call things both ways since the market moves both ways. UNLIKE YOU WITH YOU DEAD DUCK GOLDPLAT you called it one way and got stuck, breaking the golden rule of never falling in love with a share.....as they can't love you back. At the moment all the indications are that the LION is a buy. This of course could change but then again it could not. ITS KNOWN AS SHARE DEALING AND I WILL BE DEALING TOMORROW. | 1rodson | |
08/10/2017 12:52 | pretty much sums it up KB. Miller/rodson hasn't got a clue about this stock, so he calls it both ways at the same time and then at some point in the future, he will quote his own posts, selectively of course, claiming to be right. He has done this before on alo, afpo and goldplat. It proves one thing and that is that miller/rodson does not have the ability to assess the company or its prospects with any degree of confidence or competence. | sea7 | |
08/10/2017 12:43 | 1rodson 25 Aug '17 - 19:41 - 381 of 426 0 1 Well idiots apart, looking seriously at Lion I think there is money to be made here at these prices. I already have a paper profit in one day and that can't be bad. I expect further gains throughout the coming weeks. 1rodson26 Sep '17 - 11:03 - 434 of 458 0 1 turned into a right little dead duck did this as boring as watching paint dry. Cameron is speaking tomorrow night you can guarantee the share price will fall on Thursday. 1rodson 8 Oct '17 - 12:36 - 472 of 472 0 0 ... FOR THE RECORD LIONSGOLD IS SET TO ROAR RATHER LOUDLY IN THE SHORT TERM I WOULD SUGGEST ITS A BUY AND THOSE THINKING THE SAME WOULD BE BEST GETTING IN NOW. THOSE THINKING THIS IS JUST ANOTHER RAMP.....PLEASE DISREGARD. | kimboy2 | |
08/10/2017 11:07 | this is another of miller/rodsons dogs. he said the lion would be roaring long ago, it has barely even, whimpered. They expected to be up and running by H2 2017, now it is sometime in 2018. miller/rodson can add this to his other dog calls, afpo and alo. Mind you, we mustn't forget miller/rodsons disasterous calls on goldplat at 16.5p. Going to 30p he said, actually went to 1.75p. Going lower he said, went to 8p. Not much point taking any notice of miller/rodson. | sea7 | |
07/10/2017 06:45 | I presume you have reinvested Dan. That will send a shudder through the LION market | kimboy2 | |
07/10/2017 01:00 | Yes I remember it only too well plus the fact as you rightly say, we have gained weight since then. I am surprised as you that we have not seen the promised revenue flow from TRAC since there are many out there making a mint with less than Cameron invested in similar projects......just a waiting game now. | 1rodson | |
05/10/2017 21:39 | It wasn't the one to turn sentiment, rodders, but at least it didn't send the share price back into retreat. Which will happen if we don't get some meaningful news to follow. Nearly a year since TRAC jv formed when revenue was promised for 2017 well 2017 is running out, I know Cameron is excited by it and he's paid a fair bit to get control but some numbers would be good so that we could share the excitement. As for jonnagiri we're dependent on others. Remember Cameron said more than once we were undervalued around 1.5p, well on paper we're stronger since then yet almost half the price so I should think we need to multiply from here 3x to get anywhere near what Cameron would see as fair value. And that's a tall order. | paleje |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions